Ocumetics implants intraocular lens in humans

Executive Summary

• Ocumetics Technology Corp. successfully implanted its accommodating intraocular lens in human patients, marking a historic first for the company.
• The procedures were completed without complications, representing a major inflection point in the company's 18-year development journey.
• Early postoperative results are expected in several weeks, with continuing study results to be released over several months as they become available.

Key Details

• Procedure Success: The company achieved the successful implantation of its groundbreaking accommodating intraocular lens in human subjects.
• Safety Profile: The procedures were completed without complications.
• Timeline for Data: Early postoperative results will be available in several weeks; continuing study results will be released over several months.
• Future Plans: The company will continue its first-in-human clinical trial program, with additional implantations scheduled over the coming months to validate safety and performance.
• Regulatory Path: These steps are intended to pave the way for regulatory approvals and broader clinical use.
• Product Technology: Unlike traditional monofocal or multifocal lenses, the Ocumetics lens is designed to work with the natural movements of the eye, potentially restoring the ability to see both distant and near objects clearly without glasses or contacts following cataract surgery.

Notable Quotes

• "This is a moment of immense pride for our team and everyone who has believed in Ocumetics from the beginning... Today, we celebrate this success, but we know the work is far from done." — Dean Burns, President and CEO
• "The Ocumetics accommodating intraocular lens has the potential to reshape the global standard of care first for cataract and, eventually, presbyopia patients." — Dean Burns, President and CEO